Sort
46,585 grants matching “heart failure”
Endometriosis Diagnosis and Subtypes, Reproductive History, and Cardiovascular Disease
$669,214Karen C. Schliep · University Of Utah · R01 · FY2024 · HL
Noninvasive Testing of Coronary Microvascular Reactivity Using High-resolution Free-breathing MRI
$669,107Behzad Sharif · Indiana University Indianapolis · R01 · FY2022 · HL
A Novel Approach to Cardiac Replacement with Continuous Flow Pumps
$669,069O. H. Frazier · Texas Heart Institute · R01 · FY2011 · HL
Intradialytic Myocardial Stunning in Hemodialysis Patients - a Novel Cardiovascular Risk Factor
$669,040David M Charytan · New York University School Of Medicine · R01 · FY2024 · HL
Molecular Imaging Predicts Atrial Remodeling and Fibrillation Vulnerability
$669,036Albert J Sinusas · Yale University · R01 · FY2013 · HL
Human iPSCs for Elucidating Intercellular Crosstalk Signaling in Dilated Cardiomyopathy
$669,033Joseph C Wu · Stanford University · R01 · FY2024 · HL
Cardioprotective Effect of Growth Hormone Releasing Hormone
$669,004Joshua M Hare · University Of Miami School Of Medicine · R01 · FY2017 · HL
Cardioprotective Effect of Growth Hormone Releasing Hormone
$669,004Joshua M Hare · University Of Miami School Of Medicine · R01 · FY2020 · HL
Cardioprotective Effect of Growth Hormone Releasing Hormone
$669,004Joshua M Hare · University Of Miami School Of Medicine · R01 · FY2018 · HL
Cardioprotective Effect of Growth Hormone Releasing Hormone
$669,004Joshua M Hare · University Of Miami School Of Medicine · R01 · FY2019 · HL
Evaluating the Implementation and Scale-Up of Nigeria National Sodium Reduction Program
$668,977Dike Bevis Ojji · University Of Abuja · UH3 · FY2025 · HL
Epoxyeicosatrienoic acids, diabetes, and cardiovascular disease
$668,957Rozenn Lemaitre · University Of Washington · R01 · FY2019 · HL
CV Disease in Adolescents with Type 2 Diabetes
$668,954Thomas R Kimball · Cincinnati Childrens Hosp Med Ctr · R01 · FY2007 · HL
Functional Impact of Col18a1/Endostatin Variants in PAH
$668,824Rachel L Damico · Johns Hopkins University · R01 · FY2017 · HL
BRIDGE TRIAL
$668,777Victor Hasselblad · Duke University · U01 · FY2008 · HL
Examining COVID-19 in Down Syndrome Patients Using Human iPSC-Derived Organoids
$668,755Joseph C Wu · Stanford University · R01 · FY2021 · HL
Unobtrusive Sensing of Medication Intake ("USE-MI")
$668,709Barry G Saver · Swedish Medical Center, First Hill · R01 · FY2015 · MH
Negative regulators of endothelial regeneration in aging lungs and ARDS
$668,687You-Yang Zhao · Lurie Children'S Hospital Of Chicago · R01 · FY2025 · HL
Negative regulators of endothelial regeneration in aging lungs and ARDS
$668,687You-Yang Zhao · Lurie Children'S Hospital Of Chicago · R01 · FY2023 · HL
Negative regulators of endothelial regeneration in aging lungs and ARDS
$668,687You-Yang Zhao · Lurie Children'S Hospital Of Chicago · R01 · FY2022 · HL
Activity Levels, Myosteatosis and Insulin Resistance/Diabetes Mellitus
$668,658Matthew A Allison · University Of California, San Diego · R01 · FY2022 · HL
Inward Rectifier K Channel and Ca-Dependent Arrhythmia
$668,520Jonathan C Makielski · University Of Wisconsin-Madison · P01 · FY2012 · HL
Role of group 2 innate lymphoid cells in myocardial infarction
$668,501Peter Libby · Brigham And Women'S Hospital · R01 · FY2024 · HL
Long-term Percutaneous Access Device for Home Therapies
$668,462L.Vad Technology, Inc. · R44 · FY2004 · HL
Plasmonically Enhanced Point-of-care Detection of Cardiac Biomarkers by a Smart Phone
$668,455Maiken Mikkelsen · Duke University · R01 · FY2021 · HL